Investigation of improvement of sarcopenia by suppression of hyperammonemia with rifaximin.
Not Applicable
- Conditions
- cirrhotic patient
- Registration Number
- JPRN-UMIN000048778
- Lead Sponsor
- Iwate Medical University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with liver cancer in more advanced stage than BCLC-C stage 2) Patients who will be treated for hepatocellular carcinoma within the study period. 3) Patients with serious bone or muscle disease or cardiac, pulmonary, renal, or cerebrovascular disease. 4) Pregnant or lactating women and patients who may or intend to become pregnant.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method